Magnetic resonance imaging assessment of cardiac dysfunction in δ-sarcoglycan null mice

Neuromuscular Disorders

Volumn 21, Issue 1, 2011, Pages 68-73

  Wansapura, Janaka P ^a   Millay, Douglas P ^a   Dunn, R Scott ^a   Molkentin, Jeffery D ^a   Benson, D Woodrow ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cardiac function; Dyssynchrony; Limb girdle muscular dystrophy; Sarcoglycan null

Indexed keywords

DELTA SARCOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE EJECTION FRACTION; IMAGE ANALYSIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; HEART DISEASES; HEART VENTRICLES; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REPERFUSION INJURY; SARCOGLYCANS;

EID: 78650307515     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2010.09.007     Document Type: Article

References (26)

1. Coral-Vazquez R., Cohn R.D., Moore S.A., et al. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 1999, 98:465-474.
2. Lim L.E., Campbell K.P. The sarcoglycan complex in limb-girdle muscular dystrophy. Curr Opin Neurol 1998, 11:443-452.
3. Fanin M., Melacini P., Boito C., Pegoraro E., Angelini C. LGMD2E patients risk developing dilated cardiomyopathy. Neuromuscul Disord 2003, 13:303-309.
4. Melacini P., Fanin M., Duggan D.J., et al. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve 1999, 22:473-479.
5. Durbeej M., Campbell K.P. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 2002, 12:349-361.
6. Wilding J.R., Schneider J.E., Sang A.E., Davies K.E., Neubauer S., Clarke K. Dystrophin- and MLP-deficient mouse hearts: marked differences in morphology and function, but similar accumulation of cytoskeletal proteins. FASEB J 2005, 19:79-81.
7. Zhang W., ten Hove M., Schneider J.E., et al. Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study. J Mol Cell Cardiol 2008, 45:754-760.
8. Moens P., Baatsen P.H., Marechal G. Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil 1993, 14:446-451.
9. Petrof B.J., Shrager J.B., Stedman H.H., Kelly A.M., Sweeney H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993, 90:3710-3714.
10. Axel L., Dougherty L. MR imaging of motion with spatial modulation of magnetization. Radiology 1989, 171:841-845.
11. Diwan A., Wansapura J., Syed F.M., Matkovich S.J., Lorenz J.N., Dorn G.W. Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation. Circulation 2008, 117:396-404.
12. Diwan A., Krenz M., Syed F.M., et al. Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. J Clin Invest 2007, 117:2825-2833.
13. Hor K.N., Wansapura J., Markham L.W., et al. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol 2009, 53:1204-1210.
14. Fornwalt B.K., Arita T., Bhasin M., et al. Cross-correlation quantification of dyssynchrony: a new method for quantifying the synchrony of contraction and relaxation in the heart. J Am Soc Echocardiogr 2007, 20:1330-1337. e1.
15. Delfino J.G., Fornwalt B.K., Eisner R.L., Leon A.R., Oshinski J.N. Cross-correlation delay to quantify myocardial dyssynchrony from phase contrast magnetic resonance (PCMR) velocity data. J Magn Reson Imaging 2008, 28:1086-1091.
16. Hahn A., Bach J.R., Delaubier A., Renardel-Irani A., Guillou C., Rideau Y. Clinical implications of maximal respiratory pressure determinations for individuals with Duchenne muscular dystrophy. Arch Phys Med Rehabil 1997, 78:1-6.
17. Melacini P., Vianello A., Villanova C., et al. Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. Neuromuscul Disord 1996, 6:367-376.
18. Poppe M., Cree L., Bourke J., et al. The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 2003, 60:1246-1251.
19. Petrie C.J., Mark P.B., Dargie H.J. Cardiomyopathy in Becker muscular dystrophy - does regional fibrosis mimic infarction?. J Cardiovasc Magn Reson 2005, 7:823-825.
20. Guillaume M.D., Phoon C.K., Chun A.J., Srichai M.B. Delayed enhancement cardiac magnetic resonance imaging in a patient with Duchenne muscular dystrophy. Tex Heart Inst J 2008, 35:367-368.
21. Varghese A., Pennell D.J. Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy. Heart 2004, 90:e59.
22. Puchalski M.D., Williams R.V., Askovich B., et al. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?. Int J Cardiovasc Imaging 2009, 25:57-63.
23. Suselbeck T., Haghi D., Neff W., Borggrefe M., Papavassiliu T. Midwall myocardial fibrosis in Becker-Kiener muscular dystrophy. Z Kardiol 2005, 94:465-468.
24. Silva M.C., Meira Z.M., Gurgel Giannetti J., et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 2007, 49:1874-1879.
25. Ashford M.W., Liu W., Lin S.J., et al. Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging. Circulation 2005, 112:2462-2467.
26. Schreiber A., Smith W.L., Ionasescu V., et al. Magnetic resonance imaging of children with Duchenne muscular dystrophy. Pediatr Radiol 1987, 17:495-497.